Sensus Healthcare
Updated: January 24, 2026
Joe Sardano, CEO
Country: USA | Funding: $25M (+)
Founded: 2010
Website: https://www.sensushealthcare.com/
Sensus Healthcare produces SRT - superficial radiation therapy devices for the non-invasive treatment of non-melanoma skin cancer and keloids. This is a compact and efficient device that delivers precise, painless, calibrated dose of proton beam therapy. It also offers additional features like high-frequency ultrasound for process visualization. SRT offers an alternative to surgical treatment of skin cancer, eliminating the need for incisions and reducing the risk of scarring. Unlike traditional surgery, SRT typically causes minimal discomfort during treatment (patients lie comfortably on a treatment table), allowing patients to undergo therapy with ease and return to their daily activities.
Founded: 2010
Website: https://www.sensushealthcare.com/
Sensus Healthcare produces SRT - superficial radiation therapy devices for the non-invasive treatment of non-melanoma skin cancer and keloids. This is a compact and efficient device that delivers precise, painless, calibrated dose of proton beam therapy. It also offers additional features like high-frequency ultrasound for process visualization. SRT offers an alternative to surgical treatment of skin cancer, eliminating the need for incisions and reducing the risk of scarring. Unlike traditional surgery, SRT typically causes minimal discomfort during treatment (patients lie comfortably on a treatment table), allowing patients to undergo therapy with ease and return to their daily activities.
